Brief: Cero Therapeutics And Phoenix Biotech Announce Merger Agreement

CERo Therapeutics Holdings

05/06/2023 16:05

June 5 (Reuters) - Phoenix Biotech Acquisition Corp
 PBAX.O :
    * CERO THERAPEUTICS, INC. AND PHOENIX BIOTECH ACQUISITION
CORP.
ANNOUNCE MERGER AGREEMENT TO CREATE PUBLIC COMPANY ADVANCING THE
DEVELOPMENT OF NEXT GENERATION ENGINEERED T CELL THERAPEUTICS
    * PHOENIX BIOTECH ACQUISITION CORP - TRANSACTION REFLECTS A
PRE-MONEY EQUITY VALUE OF $50 MILLION FOR CERO
    * PHOENIX BIOTECH ACQUISITION CORP - TRANSACTION REFLECTS
PRO
FORMA EQUITY CAPITALIZATION OF $145 MILLION
    * PHOENIX BIOTECH ACQUISITION CORP - COMBINED COMPANY TO BE
LISTED
ON NASDAQ UNDER TICKER "CERO"
    * PHOENIX BIOTECH ACQUISITION CORP - COMBINED COMPANY WILL
BE
NAMED CERO THERAPEUTICS HOLDINGS, INC. AND WILL BE LED BY CERO
AND PBAX'S FOUNDING MEMBERS
    * PHOENIX BIOTECH ACQUISITION CORP - BRIAN G. ATWOOD WILL
SERVE AS
CHIEF EXECUTIVE OFFICER OF COMBINED COMPANY
    * PHOENIX BIOTECH ACQUISITION CORP - CHRIS EHRLICH WILL
SERVE AS
COMBINED CO'S CFO & CHIEF OPERATING OFFICER

Source text for Eikon:  ID:nBwvH7nja 
Further company coverage:  PBAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))